Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy

Cited by (312)

Items 101–200 of 312

1. Mild phototherapy mediated by manganese dioxide-loaded mesoporous polydopamine enhances immunotherapy against colorectal cancer
   Caiying Li, Tan Li, Kexin Niu, Zecong Xiao, Jing Huang, Ximin Pan, Yi Sun, Yongchen Wang, Decai Ma, Peiyi Xie et al. · 2022 · Biomaterials Science
2. Mechanism underlying circRNA dysregulation in the TME of digestive system cancer
   Zeyu Wu, Xiao Yu, Shuijun Zhang, Yuting He, Wenzhi Guo · 2022 · Frontiers in Immunology
3. Tumor Microenvironment Regulation and Cancer Targeting Therapy Based on Nanoparticles
   Shulan Han, Yongjie Chi, Zhu Yang, Juan Ma, Lianyan Wang · 2023 · Journal of Functional Biomaterials
4. Prognostic and tumor microenvironmental feature of clear cell renal cell carcinoma revealed by m6A and lactylation modification-related genes
   Lin Yang, Xiaoyu Wang, Jiahao Liu, Xiaoqiang Liu, Sheng Li, Fuchun Zheng, Qianxi Dong, Songhui Xu, Jing Xiong, Bin Fu · 2023 · Frontiers in Immunology
5. Roles of circRNAs in regulating the tumor microenvironment
   Tao Liu, Kaijun Long, Zhengfeng Zhu, Yongxiang Song, Cheng Chen, G. Wei Xu, Xixian Ke · 2023 · Medical Oncology
6. Gut Microbiota and Mental Health: A Comprehensive Review of Gut-Brain Interactions in Mood Disorders
   Ishani Mehta, Keshav Juneja, Tharun Nimmakayala, Lajpat Rai Bansal, Shivani Pulekar, Dileep Duggineni, Hana Khan Ghori, Nishi M Modi, Salma Younas · 2025 · Cureus
7. Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems
   Yan-Ting Sun, Yuling Li, Shuo Shi, Chun-Yan Dong · 2021 · Molecules
8. Hypoxia-Induced LncRNA-MIR210HG Promotes Cancer Progression By Inhibiting HIF-1α Degradation in Ovarian Cancer
   Ping Liu, Huiqiong Huang, Xiaorong Qi, Ce Bian, Meng Cheng, Lili Liu, Luqi Xue, Xia Zhao, Tao Yi, Yi Quan · 2021 · Frontiers in Oncology
9. Research advances in mechanism of antiangiogenic therapy combined with immune checkpoint inhibitors for treatment of non-small cell lung cancer
   Dan-Ming He, Lu Wang, Jia-Chen Xu, Jie Zhao, Hua Bai, Jie Wang · 2023 · Frontiers in Immunology
10. Cancer immunotherapy: Classification, therapeutic mechanisms, and nanomaterial-based synergistic therapy
    Xiangyu Meng, Yunfeng Lei, Xuezhong Zhang, Kai Sun, Liming Zhang, Zhifei Wang · 2021 · Applied Materials Today
11. Ferroptosis-related molecular patterns reveal immune escape, inflammatory development and lipid metabolism characteristics of the tumor microenvironment in acute myeloid leukemia
    Fangmin Zhong, Fangyi Yao, Jing Liu, Haibin Zhang, Jing Zhang, Nan Zhang, Lin Jin, Shuqi Li, Mei‐Yong Li, Junyao Jiang et al. · 2022 · Frontiers in Oncology
12. Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding
    Carla Riera‐Domingo, Eduarda Leite-Gomes, Iris Charatsidou, Peihua Zhao, Giovanna Carrà, Federica Cappellesso, Larissa Mourão, Maxim De Schepper, Dana Liu, Jens Serneels et al. · 2023 · Science Advances
13. Single-cell integrative analysis reveals consensus cancer cell states and clinical relevance in breast cancer
    Lin Pang, Fengyu Xiang, Huan Min Yang, Xinyue Shen, Ming Fang, Ran Li, Yongjin Long, Jiali Li, Yonghuan Yu, Bo Pang · 2024 · Scientific Data
14. Immune interactions in pembrolizumab (PD-1 inhibitor) cancer therapy and cardiovascular complications
    Abha Banerjee, Chandrakala Aluganti Narasimhulu, Dinender Kumar Singla · 2023 · American Journal of Physiology-Heart and Circulatory Physiology
15. Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
    Kai Wen, Yongcong Yan, Juanyi Shi, Lei Hu, Weidong Wang, Hao Liao, Huoming Li, Yue Zhu, Kai Mao, Zhiyu Xiao · 2021 · Frontiers in Molecular Biosciences
16. Hypoxic Non-Small-Cell Lung Cancer Cell-Secreted Exosomal microRNA-582-3p Drives Cancer Cell Malignant Phenotypes by Targeting Secreted Frizzled-Related Protein 1
    Jian Wang, Jia Zhao, Jinsong Zhu, Shengli Zhang · 2020 · Cancer Management and Research
17. Comprehensive molecular and clinical characterization of SLC1A5 in human cancers
    Han Zhang, Kaisa Cui, Surui Yao, Yuan Yin, Dengyang Liu, Zhaohui Huang · 2021 · Pathology - Research and Practice
18. Macrophage mitochondrial bioenergetics and tissue invasion are boosted by an Atossa‐Porthos axis in Drosophila
    Shamsi Emtenani, Elliot Todd Martin, Attila Gyoergy, Julia Bicher, Jakob‐Wendelin Genger, Thomas Köcher, Maria Akhmanova, Mariana Guarda, Marko Roblek, Andreas Bergthaler et al. · 2022 · The EMBO Journal
19. Cell cycle inhibitors activate the hypoxia-induced DDX41/STING pathway to mediate antitumor immune response in liver cancer
    Po Yee Wong, Cerise Yuen Ki Chan, Helen Do Gai Xue, Chi Ching Goh, Jacinth Wing‐Sum Cheu, Aki Pui‐Wah Tse, Misty Shuo Zhang, Yan Zhang, Carmen Chak‐Lui Wong · 2024 · JCI Insight
20. Empowering hypoxia to convert cold tumors into hot tumors for breast cancer immunotherapy
    Lu Liu, Danping Wu, Zhiwen Qian, Jiang Ying, Yilan You, YiDa Wang, Feng Zhang, Xin Ning, Jie Mei, Jabed Iqbal et al. · 2025 · Cell Death Discovery
21. The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy
    Alberto Cruz‐Bermúdez, Raquel Laza Briviesca, Marta Casarrubios, Belén Sierra‐Rodero, Mariano Provencio · 2021 · Biomedicines
22. Characterization of Hypoxia-Related Molecular Subtypes in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy and Targeted Therapy via Multi-Omics Analysis
    Weimin Zhong, Hongbin Zhong, Fengling Zhang, Chaoqun Huang, Yao Lin, Jiyi Huang · 2021 · Frontiers in Molecular Biosciences
23. Multi-Omics Profiling Identifies Risk Hypoxia-Related Signatures for Ovarian Cancer Prognosis
    Xingyu Chen, Hua Lan, Dong He, Runshi Xu, Yao Zhang, Yaxin Cheng, Haotian Chen, Songshu Xiao, Ke Cao · 2021 · Frontiers in Immunology
24. Targeting tumor O‐glycosylation modulates cancer–immune‐cell crosstalk and enhances anti‐ PD ‐1 immunotherapy in head and neck cancer
    Mei‐Chun Lin, Ya‐Ting Chuang, Hsin‐Yi Wu, Chia‐Lang Hsu, Neng‐Yu Lin, Min‐Chuan Huang, Pei‐Jen Lou · 2023 · Molecular Oncology
25. Ovarian Cancer and the Microbiome: Connecting the Dots for Early Diagnosis and Therapeutic Innovations—A Review
    Seo-Yoon Choi, Jung‐Hye Choi · 2024 · Medicina
26. Autophagy‐Inducing MoO 3‐x Nanowires Boost Photothermal‐Triggered Cancer Immunotherapy
    Lizhen He, Qi Chen, Qichen Lu, Meijin Yang, Bin Xie, Tianfeng Chen, Xun Wang · 2024 · Angewandte Chemie International Edition
27. Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy
    Chen Chen, Peng Han, Yanping Qing · 2024 · Autoimmunity Reviews
28. Probing the Potential of Defense Response-Associated Genes for Predicting the Progression, Prognosis, and Immune Microenvironment of Osteosarcoma
    Liangkun Huang, Fei Sun, Haohuan Li, Wenyi Jin, Yubiao Zhang, Junwen Chen, Changheng Zhong, Wanting Liang, Hao Peng · 2023 · Cancers
29. Treatment Strategies and Metabolic Pathway Regulation in Urothelial Cell Carcinoma: A Comprehensive Review
    Huang‐Yu Yang, Chao‐Yi Wu, Jia‐Jin Chen, Tao Han Lee · 2020 · International Journal of Molecular Sciences
30. Age- and diet-instructed metabolic rewiring of the tumor–immune microenvironment
    Ana Belén Plata-Gómez, Ping‐Chih Ho · 2025 · The Journal of Experimental Medicine
31. Hypoxia orchestrates the lymphovascular–immune ensemble in cancer
    Luana Schito, Sergio Rey · 2022 · Trends in cancer
32. Biomimetic phototherapy in cancer treatment: from synthesis to application
    Yifan Zhao, Cuixia Shi, Jie Cao · 2021 · Drug Delivery
33. Colorectal cancer: the immune microenvironment and the gut microbiota – new perspectives, challenges, and opportunities
    Ping Zhou, Wangzheqi Zhang, Yan Liao, Zhiyong Zhai, Sicun Lu, Shuya Jiang, Wei Hu, Wei Gong · 2025 · International Journal of Surgery
34. LAMP2 as a Biomarker Related to Prognosis and Immune Infiltration in Esophageal Cancer and Other Cancers: A Comprehensive Pan-Cancer Analysis
    Shan-peng Liu, Xiaomin Li, Dan-man Liu, Shu-Huan Xie, Shao-bo Zhang, Yu Li, Zefeng Xie · 2022 · Frontiers in Oncology
35. Identification and Validation of a Metabolism-Related Prognostic Signature Associated with M2 Macrophage Infiltration in Gastric Cancer
    Yunze Liu, Haocheng Zheng, Anna Meilin Gu, Yuan Li, Tieshan Wang, Chengze Li, Yixiao Gu, Jie Lin, Xia Ding · 2023 · International Journal of Molecular Sciences
36. Co-expression based cancer staging and application
    Xiangchun Yu, Sha Cao, Yi Zhou, Zhezhou Yu, Ying Xu · 2020 · Scientific Reports
37. Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer
    Meng Yuan, Yirui Zhai, Yu Men, Maoyuan Zhao, Xin Sun, Zeliang Ma, Xu Yang, Shuang Sun, Yongxing Bao, Yunsong Liu et al. · 2022 · Thoracic Cancer
38. Integrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable prognosis in pancreatic adenocarcinoma
    Mingwei Dong, Rong Tang, Wei Wang, Jin Xu, Jiang Liu, Chen Liang, Jie Hua, Qingcai Meng, Xianjun Yu, Bo Zhang et al. · 2023 · Translational Oncology
39. Manganese-based nanomaterials promote synergistic photo-immunotherapy: green synthesis, underlying mechanisms, and multiple applications
    Yuanyuan Cao, Yilin Li, Caixia Ren, Chengkai Yang, Rongzhang Hao, Tiancheng Mu · 2024 · Journal of Materials Chemistry B
40. A novel hypoxia- and lactate metabolism-related prognostic signature to characterize the immune landscape and predict immunotherapy response in osteosarcoma
    Yizhuo Wang, Xin Wei Wang, Yang Liu, Jiayuan Xu, Jiyuan Zhu, Yufu Zheng, Qi Quan · 2024 · Frontiers in Immunology
41. Spatial transcriptomics reveals unique metabolic profile and key oncogenic regulators of cervical squamous cell carcinoma
    Li-Min Zhou, Jie-Jie Liu, Peipei Yao, Xing Liu, Fei Chen, Yu Chen, Li Zhou, Chao Shen, You Zhou, Xin Du et al. · 2024 · Journal of Translational Medicine
42. The Complexity of Malignant Glioma Treatment
    Linde F. C. Kampers, Dennis Serge Metselaar, Maria Vinci, Fabio Scirocchi, Sophie E. M. Veldhuijzen van Zanten, Matthias K. Eyrich, Veronica Biassoni, Esther Hulleman, Michael Karremann, Wilfried Stücker et al. · 2025 · Cancers
43. Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer
    Hongxian Zhang, Jiwen Song, Junqiang Dong, Zhuo Liu, Lixuan Lin, Bing Wang, Qiang Ma, Lulin Ma · 2021 · Frontiers in Genetics
44. Construction of immune-related signature and identification of S100A14 determining immune-suppressive microenvironment in pancreatic cancer
    Chengcheng Wang, Yuan Chen, Xinpeng Yin, Ruiyuan Xu, Jianlu Song, Rexiati Ruze, Qiang Xu, Yupei Zhao · 2022 · BMC Cancer
45. A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma
    Genhao Zhang, Kai Zhang, Yanteng Zhao, Qiankun Yang, Xianping Lv · 2022 · BMC Cancer
46. RNF8 enhances the sensitivity of PD-L1 inhibitor against melanoma through ubiquitination of galectin-3 in stroma
    Yanan Guo, Rong Shen, Keren Yang, Yutong Wang, Haoyun Song, Xiangwen Liu, Xin Cheng, Rile Wu, Yanfeng Song, Degui Wang · 2023 · Cell Death Discovery
47. Catalase-gold nanoaggregates manipulate the tumor microenvironment and enhance the effect of low-dose radiation therapy by reducing hypoxia
    Alireza Najafi, Maryam Keykhaee, Mohammad Hossein Kazemi, Mohammad Yahya Karimi, Hossein Khorramdelazad, Nazanin Aghamohamadi, Mohammad Reza Bolouri, Haniyeh Ghaffari Nazari, Ensie Sadat Mirsharif, Milad Karimi et al. · 2023 · Biomedicine & Pharmacotherapy
48. Machine learning and experiments identifies SPINK1 as a candidate diagnostic and prognostic biomarker for hepatocellular carcinoma
    Shiming Yi, Chunlei Zhang, Ming Li, Tianyi Qu, Jiafeng Wang · 2023 · Discover Oncology
49. Composite bioreactor for synergistic Modulation of tumor microenvironment and endogenous Regulation of ROS generation to enhance chemodynamic therapy for lung cancer
    Longhao Lv, Yong Liu, Chengsong Cao, Yong Li, Zhengshuai Tang, Jinliang Liu · 2025 · Journal of Colloid and Interface Science
50. Ultrasound and laser-promoted dual-gas nano-generator for combined photothermal and immune tumor therapy
    Xinyu Li, Yong Ming Gao, Xinzheng Liu, XiaoQian Hu, YunMeng Li, JunXi Sun, PingYu Wang, Hongkai Wu, Hae‐Won Kim, Murugan Ramalingam et al. · 2022 · Frontiers in Bioengineering and Biotechnology
51. Comprehensive Analysis of Prognostic Markers for Acute Myeloid Leukemia Based on Four Metabolic Genes
    Yuanyuan Zhang, Shengling Ma, Moran Wang, Wei Shi, Yu Hu · 2020 · Frontiers in Oncology
52. Tumor Microenvironment: An Emerging Landscape for Lung Cancer Therapy
    S. M. Sohag, Sharmin Nur Toma, Md. Al-Imran Imon, Maiweilan Maihemuti, Famim Ahmed, Mst. Afsana Mimi, Imran Mahmud, Md. Mahmudul Hasan · 2025 · Future Pharmacology
53. Hypoxia Boosts Aerobic Glycolysis in Carcinoma: A Complex Process for Tumour Development
    Xiuqin Zheng, Hui Jie Fan, Yang Liu, Zhonghong Wei, Xiaoman Li, Aiyun Wang, Wenxing Chen, Yin Lu · 2021 · Current Molecular Pharmacology
54. Three-Dimensional Spheroids for Cancer Research
    Melissa Anne Tutty, Adriele Prina‐Mello · 2023 · Methods in molecular biology
55. Endoplasmic Reticulum Stress Potentiates the Immunosuppressive Microenvironment in Hepatocellular Carcinoma by Promoting the Release of SNHG6-Enriched Small Extracellular Vesicles
    Chengdong Liu, Xiaohan Zhou, Hanyi Zeng, Jiaping Yu, Wenwen Li, Wanli Zhang, Yanxia Liao, Haijian Wang, Li Liu · 2024 · Cancer Immunology Research
56. A Novel Glycolysis and Hypoxia Combined Gene Signature Predicts the Prognosis and Affects Immune Infiltration of Patients with Colon Cancer
    Guochao Mao, Jianhua Wu, Hanxiao Cui, Luyao Dai, Li Ma, Zhangjian Zhou, Baobao Liang, Shuqun Zhang, Shuai Lin · 2022 · International Journal of General Medicine
57. T cells in the peritoneum
    Sanjay Rathod · 2022 · International review of cytology
58. The Dog as a Model to Study the Tumor Microenvironment
    Maria Isabel Carvalho, Teresa Pereira Raposo, Ricardo Silva-Carvalho, Isabel Cristina Ribeiro Pires, Justina Prada, Hugo Gregório, FELISBINA LUISA QUEIROGA · 2021 · Advances in experimental medicine and biology
59. Development and Verification of a Hypoxic Gene Signature for Predicting Prognosis, Immune Microenvironment, and Chemosensitivity for Osteosarcoma
    Fengfeng Wu, Juntao Xu, Mingchao Jin, Xuesheng Jiang, Jianyou Li, Xiongfeng Li, Zhuo Chen, Jiangbo Nie, Zhipeng Meng, Guorong Wang · 2022 · Frontiers in Molecular Biosciences
60. Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy
    Qi Wei, Lening Zhang, Nan Zhao, Zhihua Cheng, Xin Hua, Jianxun Ding · 2022 · Frontiers in Immunology
61. Benign non-immune cells in tumor microenvironment
    Shaowen Liu, Chunhui Liu, Yuan He, Jun Li · 2025 · Frontiers in Immunology
62. Prediction of Lung Cancer Metastasis Risk Based on Single‐Cell Metabolic Profiling of Circulating Tumor Cells
    Yang Xu, Xuesen Hu, Yuan Yuan, Wenwen Liu, Jian Wang, Chunhui Yang, Xianzhe Shi, Wangshu Qin, Liliang Wen, Manqing Lin et al. · 2025 · Advanced Science
63. Cuproptosis scoring model predicts overall survival and assists in immunotherapeutic decision making in pancreatic carcinoma
    Tijun Liu, Qing Liu, Yongju Wang, Rong Yang, Fang Tian · 2022 · Frontiers in Genetics
64. Construction of novel hypoxia-related gene model for prognosis and tumor microenvironment in endometrial carcinoma
    Junfeng Chen, Guocheng Wang, Donghai Zhang, Xiaomei Luo, Da Zhang, Yongli Zhang · 2022 · Frontiers in Endocrinology
65. Multiparameter prediction model of immune checkpoint inhibitors combined with chemotherapy for non-small cell lung cancer based on support vector machine learning
    Zihan Zhou, Wenjie Guo, Dingqi Liu, J. Micha, Yue Song, Shuhua Han · 2023 · Scientific Reports
66. Hypoxia is correlated with the tumor immune microenvironment: Potential application of immunotherapy in bladder cancer
    Haotian Chen, Yao Zhang, Xingyu Chen, Runshi Xu, Yuxing Zhu, Dong He, Yaxin Cheng, Zhanwang Wang, Xiang Qing, Ke Cao · 2023 · Cancer Medicine
67. Hypoxia Potentiated Lung Cancer Cell Migration and Invasion by up-regulating HIF1α/JAK2/STAT3 Axis and Activating MMP13 Transcription
    Xiaoju Cheng, Damin Liang, Xiaoqian Li, Chengmin Deng, Meng Ye, Yang Jiao, Yurui Liu, Kaifeng Wu, Jie Wu, Peng Tian · 2023 · Cell Biochemistry and Biophysics
68. Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models
    Hongyan Zheng, Lihua Wu, Jianfeng Chen, Na Na, Ge Lou · 2024 · Breast Cancer
69. Co-morbid intersections of cancer and cardiovascular disease and targets for natural drug action: Reprogramming of lipid metabolism
    Guanghui Zhu, Luchang Cao, Jingyuan Wu, Manman Xu, Ying Zhang, Min Wu, Jie Li · 2024 · Biomedicine & Pharmacotherapy
70. 8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma
    Congbo Cai, Lei Yang, Kena Zhou · 2021 · BMC Gastroenterology
71. Metabolomics, Transcriptomics and Functional Glycomics Reveals Bladder Cancer Cells Plasticity and Enhanced Aggressiveness Facing Hypoxia and Glucose Deprivation
    Andreia Peixoto, Rui Freitas, Dylan Ferreira, Marta Relvas‐Santos, Paula Paulo, Marta Cardoso, Janine Soares, Cristiana Gaiteiro, Carlos Palmeira, Filipe Teixeira et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
72. Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma
    Priyanka Shailendra Rana, Krishna Goparaju, James Joseph Driscoll · 2023 · Frontiers in Oncology
73. Unraveling the influence of metabolic signatures on immune dynamics for predicting immunotherapy response and survival in cancer
    Qiyun Ou, Kevin Lu, Gengyi Cai, Zijia Lai, Ruicong Lin, Hong Huang, Dongqiang Zeng, Zehua Wang, Baoming Luo, Wenhao Ouyang et al. · 2024 · MedComm – Future Medicine
74. Hypoxia-driven metabolic heterogeneity and immune evasive behaviour of gastrointestinal cancers: Elements of a recipe for disaster
    Ashish Kumar Mishra, Siddharth Singh, Sruthilaya Dayanandan, Smaran Banerjee, Soumyadeep Chakraborty, Akshita Baiju Gopal, Supriya Samal, Indrajit Poirah, Debashish Chakraborty, Asima Bhattacharyya · 2022 · Cytokine
75. Construction of a Combined Hypoxia-related Genes Model for Hepatocellular Carcinoma Prognosis
    Liping Ren, Xianrun Pan, Ning Lin, Di Gong, Jian Hua Huang, Kejun Deng, Lei Xie, Yang Zhang · 2022 · Current Computer - Aided Drug Design
76. Pathologic Response to Neoadjuvant Sequential Chemoradiation Therapy in Locally Advanced Breast Cancer: Preliminary, Translational Results from the French Neo-APBI-01 Trial
    Nhu Hanh To, Isabelle Gabelle-Flandin, Thi My Hanh Luong, Gokoulakrichenane Loganadane, Nabila Ouidir, Chahrazed Boukhobza, Noémie Grellier, Camille Verry, Allan Thiolat, José Laurent Cohen et al. · 2023 · Cancers
77. The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancer
    Mingxiu Ju, Baoyue Pan, Yongwen Huang, Yun Zhou, Jieping Chen, Huiling Xiang, Shije Xu, Siyu Chen, Chunyan Lan, Jundong Li et al. · 2024 · Cancer Medicine
78. Nano‐ablative immunotherapy for cancer treatment
    Ashley R. Hoover, Kai‐Li Liu, Trisha I. Valerio, Min Li, Priyabrata Mukherjee, Wei R. Chen · 2021 · Nanophotonics
79. A-Kinase Interacting Protein 1 Promotes Cell Invasion and Stemness via Activating HIF-1α and β-Catenin Signaling Pathways in Gastric Cancer Under Hypoxia Condition
    Zhenqin Luo, Yuhang Luo, Ke Xiao · 2022 · Frontiers in Oncology
80. Construction of a prognostic glycolysis‐related lncRNA signature for patients with colorectal cancer
    Xinyang Zhong, Xuefeng He, Yaxian Wang, Zijuan Hu, Huixia Huang, Senlin Zhao, Hong Zhang, Ping Wei, Dawei Li · 2022 · Cancer Medicine
81. Targeting PGK1: A New Frontier in Breast Cancer Therapy Under Hypoxic Conditions
    Jiayong Cui, Shengjun Chai, Rui Liu, Guoshuang Shen · 2024 · Current Issues in Molecular Biology
82. Contribution of the immune bone marrow microenvironment to tumor growth and bone deconstruction: implications for improving immunotherapeutic strategies in bone metastasis
    Emmanuel Massy, Cyrille B. Confavreux, Mathieu Point, Edith Bonnelye, Philippe Clézardin · 2025 · Neoplasia
83. High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT
    Hsin‐Pao Chen, Chih‐I Chen, Kuang-Wen Liu, Tzu‐Ju Chen, Yufeng Tian, Yu‐Hsuan Kuo, Wan‐Shan Li, Hsin-Hwa Tsai, Li-Ching Wu, Cheng-Fa Yeh et al. · 2022 · Pathology - Research and Practice
84. Characterization of heterogeneous metabolism in hepatocellular carcinoma identifies new therapeutic target and treatment strategy
    Jiabin Yang, Liangtang Zeng, Ruiwan Chen, Shangyou Zheng, Yu Zhou, Rufu Chen · 2023 · Frontiers in Immunology
85. Research Hotspots and Trends in Global Cancer immunometabolism:A Bibliometric Analysis from 2000 to 2023
    Shupeng Chen, Jie Liu, G Q He, Nana Tang, Yingjian Zeng · 2024 · Journal of Multidisciplinary Healthcare
86. mGWAS identification of six novel single nucleotide polymorphism loci with strong correlation to gastric cancer
    Shuangfeng Yang, Yuanliang Wang, Yanping Lyu, Yu Jiang, Jianjun Xiang, Shumi Ji, Shuling Kang, Xuejie Lyu, Chenzhou He, Peixin Li et al. · 2021 · Cancer & Metabolism
87. The Immune Cell Infiltration Patterns and Characterization Score in Bladder Cancer to Identify Prognosis
    Yongsheng Zhang, Yunlong Wang, Jichuang Wang, Kaixiang Zhang · 2022 · Frontiers in Genetics
88. Multi-omics characterization of a scoring system to quantify hypoxia patterns in patients with head and neck squamous cell carcinoma
    Cong Peng, Huiping Ye, Zhengyang Li, Xiaofeng Duan, Wen Jin Yang, Zhuguang Yi · 2023 · Journal of Translational Medicine
89. Integrating bulk and single‐cell data to predict the prognosis and identify the immune landscape in HNSCC
    Chunlong Yang, Xiaoning Cheng, Shenglan Gao, Qingjun Pan · 2023 · Journal of Cellular and Molecular Medicine
90. Metabolic traits ruling the specificity of the immune response in different cancer types
    Nina C. Flerin, Federica Cappellesso, Samantha Pretto, Massimiliano Mazzone · 2020 · Current Opinion in Biotechnology
91. ENPEP as a potential predictor of immune checkpoint inhibitor efficacy
    Aoyun Wang, Han Chu, Zheng Jin, Zhihua Gong, Qingzhu Jia, Bo Zhu · 2021 · Cancer Medicine
92. Metabolic reprogramming through PIM3 inhibition reverses hypoxia-induced CAR-T cell dysfunction in solid tumors
    Muya Zhou, Luxia Xu, Jinhua Hu, Wenwen Chen, Jialu Hong, M.-H. Wang, Zhigang Guo · 2025 · Journal of Translational Medicine
93. Immunoglobulin‐like transcript 5 polarizes M2 ‐like tumor‐associated macrophages for immunosuppression in non‐small cell lung cancer
    Huijun Xu, Xuebing Fu, Shuyun Wang, Yihui Ge, Lu Zhang, Juan Li, Fang Zhang, Yang Yang, Yifu He, Yuping Sun et al. · 2025 · International Journal of Cancer
94. A metabolism-relevant signature as a predictor for prognosis and therapeutic response in pancreatic cancer
    Qiangda Chen, Ning Pu, Hanlin Yin, Jicheng Zhang, Guochao Zhao, Wenhui Lou, Wenchuan Wu · 2021 · Experimental Biology and Medicine
95. Identification of a novel necroptosis-related classifier to predict prognosis and guide immunotherapy in breast invasive carcinoma
    Qin Zhou, Yan Xu, Liang Shen, Xiaochen Yang, Li Wang · 2022 · Frontiers in Oncology
96. PPARα Agonism Enhances Immune Response to Radiotherapy While Dietary Oleic Acid Results in Counteraction
    Richard Blake Ross, Jacob Gadwa, Justin Yu, Laurel B. Darragh, Michael W. Knitz, Diemmy Nguyen, Nicholas A. Olimpo, Khalid N.M. Abdelazeem, Alexander T. Nguyen, Sophia Corbo et al. · 2024 · Clinical Cancer Research
97. Construction and Verification of a Hypoxia-Stemness-Based Gene Signature for Risk Stratification in Esophageal Cancer
    Kang Lai Tang, Yong Cheng, Qian Li · 2021 · Medical Science Monitor
98. Predictive value of hypoxia, metabolism and immune factors for prognosis in hepatocellular carcinoma: a retrospective analysis and multicenter validation study
    Peng Lin, Dong‐yue Wen, Gang Chen, Yi‐Wu Dang, Yun He, Hong Yang · 2020 · Journal of Cancer
99. Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei
    Qidi Zhao, Tian Wei, Ru Ma, Yu‐Bin Fu, Rui Yang, Yandong Su, Yang Yu, Bing Li, Yan Li · 2024 · Cancer Biology and Medicine
100. Unveiling the role of Pleckstrin-2 in tumor progression and immune modulation: insights from a comprehensive pan-cancer analysis with focus on lung cancer
     Enzhi Yin, Chengming Liu, Yuxin Yao, Yuejun Luo, Yaning Yang, Xiaoya Tang, Sufei Zheng, Linyan Tian, Jie He · 2024 · Molecular Biomedicine